July 17th 2025
A large study looked at booster uptake and effectiveness among US adults who received chemotherapy or immunotherapy.
Genetically Diverse Viral Antigens Needed to Win the Fight Against Viral Pathogens
August 21st 2016A new model of the within-host evolutionary arms race between viral pathogens and the adaptive immune responses intended to fight them suggests that vaccines based on genetically diverse sets of viral antigens may be more likely to stimulate the production of antibodies capable of neutralizing broad panels of virions.
Read More
New RNA Vaccines May Reduce Disease Outbreak Response Time
August 3rd 2016Engineers at the Massachusetts Institute of Technology have developed a new type of customizable vaccines using messenger RNA that has proven to effectively combat a wide range of lethal pathogens when administered to mice, and might be able to reduce disease outbreak response time in the future.
Read More
Have Researchers Finally Found the Key to a Universal Influenza Vaccine?
July 28th 2016Investigators at the National Institute of Allergy and Infectious Diseases (NIAID) and the National Human Genome Research Institute (NHGRI) believe they have found the key to developing a universal vaccine for influenza.
Read More
New Vaccine Development Strategy for Leishmaniasis Shows Promise
June 3rd 2016Management of visceral leishmaniasis poses a daunting challenge, in part due to the side effects associated with the use of the traditional treatment. However, one vaccine development strategy has recently shown promising results.
Read More
Influenza Vaccine During Pregnancy May Protect Newborn Infants
May 31st 2016The number of expecting mothers who opt for annual vaccination for influenza during pregnancy remains relatively low; however, the results of a new study suggest this may be changing—and that there are obvious benefits for immunization for newborns.
Read More
Research on Universal Vaccine for Influenza Uncovers More Than Just Financial Limitations
May 2nd 2016A recent review article on the status of influenza vaccines, their short-comings, and ways to improve them suggests the potential for significant improvements in the performance of future influenza vaccines.
Read More
New Study Finds a Link between a Person's Ethnicity and Response to the Influenza Vaccine
March 1st 2016Researchers from the Dana-Farber Cancer Institute in Boston, MA have, for the first time, identified a link between a person's genetic make-up, as well as their ethnic background, and their response to influenza vaccine.
Read More